首页|基于生物信息学研究补体C3在肾透明细胞癌中的表达及临床价值

基于生物信息学研究补体C3在肾透明细胞癌中的表达及临床价值

Study on the Expression and Clinical Value of C3 in Kidney Renal Clear Cell Carcinoma Based on Bioinformatics

扫码查看
目的:研究补体C3(Complement 3,C3)在肾透明细胞癌(Kidney Renal Clear Cell Carcinoma,KIRC)中的表达、预后和免疫相关性,用于评估KIRC患者预后的价值.方法:通过UALCAN、MethHC 2.0、GEPIA、SangerBox多个在线数据库中有关C3的数据,对C3与KIRC的关系进行生物信息学分析.结果:KIRC组织中C3水平显著高于正常组织(p<0.05);患者临床特征相关性结果指出,C3 高表达与肿瘤分期、性别、年龄、肿瘤病理学分级、淋巴结转移状态及分子亚型存在相关性;预后结果显示C3 高表达患者的无病生存期、总体生存期、无进展生存期和疾病特异性生存期缩短,表明患者预后较差;C3 高表达与B细胞、巨噬细胞、中性粒细胞、树突状细胞、CD4+T细胞浸润程度呈正相关性.结论:C3 在KIRC患者中高表达是KIRC患者预后的危险因素,有望作为KIRC的预后生物标志物,为KIRC诊治提供重要指导.
Objective:To investigate the expression of complement 3(C3)in kidney renal clear cell carcinoma(KIRC)and its correlation with prognosis and.Methods:The relationship between C3 and KIRC is analyzed by using the data of C3 in multiple online databases,including UALCAN,MethHC 2.0,GEPIA and SangerBox.Results:The level of C3 in KIRC tissues is significantly higher than that in normal tissues(p<0.05).The results show that the high expression of C3 is correlated with tumor stage,sex,age,pathological grade,lymph node metastasis status and molecular subtype.Prognosis results show that disease free survival,overall survival,progression free survival and disease free survival are shortened in patients with high C3 expression,indicating poor prognosis.The high expression of C3 is positively correlated with the infiltration degree of B cells,macrophages,neutrophils,dendritic cells and CD4+T cells.Conclusion:C3 is highly expressed in KIRC patients,which is a risk factor for the prognosis of KIRC patients.It is expected to be used as a prognostic biomarker for KIRC and provide important guidance for the diagnosis and treatment of KIRC.

kidney renal clear cell carcinomacomplement 3prognosisbiomarkersbioinformatics

古伟汉、刘剑锋、闫岩、周仁龙

展开 >

嘉应学院 医学院,广东梅州 514000

广州中医药大学深圳医院 检验科,广东深圳 518000

广东新安职业技术学院 医药健康学院,广东深圳 518000

深圳市龙华区中心医院 输血科,广东深圳 518000

展开 >

肾透明细胞癌 补体C3 预后 生物标志物 生物信息学

深圳市龙华区医疗卫生机构区级科研项目

2022102

2024

生物化工

生物化工

ISSN:
年,卷(期):2024.10(4)
  • 4